Retractable Technologies (RVP) Liabilities and Shareholders Equity (2010 - 2026)
Retractable Technologies' (RVP) quarterly Liabilities and Shareholders Equity came in at $137.6 million in Q1 2026, down 7.84% YoY from $149.3 million in Q1 2025, and down 3.53% on a QoQ basis from $142.6 million in Q4 2025.
Retractable Technologies (RVP) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $137.6 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 7.84% year-over-year to $137.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $573.8 million (down 8.72% YoY) and the FY2025 annual result came in at $142.6 million, down 11.26% from the prior year.
- Liabilities and Shareholders Equity fell to $137.6 million in Q1 2026, from $142.6 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $207.5 million in Q1 2022 to a low of $137.6 million in Q1 2026.
- A 5-year average of $171.6 million and a median of $176.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity surged 49.89% — and 2025, when it decreased 15.15%.
- Tracing RVP's Liabilities and Shareholders Equity over 5 years: stood at $195.7 million in 2022, then slipped by 8.17% to $179.7 million in 2023, then fell by 10.55% to $160.7 million in 2024, then retreated by 11.26% to $142.6 million in 2025, then fell by 3.53% to $137.6 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $137.6 million (Q1 2026), $142.6 million (Q4 2025), and $146.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 20.88 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 31.10 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 8.97 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 39.35 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 14.24 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 12.48 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 19.79 Bn |
| 10 | Retractable Technologies | 21.67 Mn | -18.20 Mn | 190,852.00 | 141.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 137.60 Mn |
| Dec 31, 2025 | 142.63 Mn |
| Sep 30, 2025 | 146.43 Mn |
| Jun 30, 2025 | 147.09 Mn |
| Mar 31, 2025 | 149.31 Mn |
| Dec 31, 2024 | 160.72 Mn |
| Sep 30, 2024 | 157.81 Mn |
| Jun 30, 2024 | 160.74 Mn |
| Mar 31, 2024 | 175.98 Mn |
| Dec 31, 2023 | 179.67 Mn |
| Sep 30, 2023 | 181.52 Mn |
| Jun 30, 2023 | 186.77 Mn |
| Mar 31, 2023 | 193.66 Mn |
| Dec 31, 2022 | 195.67 Mn |
| Sep 30, 2022 | 200.58 Mn |
| Jun 30, 2022 | 194.28 Mn |
| Mar 31, 2022 | 207.50 Mn |
| Dec 31, 2021 | 206.30 Mn |
| Sep 30, 2021 | 177.99 Mn |
| Jun 30, 2021 | 175.70 Mn |